Clinical trial
New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)
NCT00520962 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 1997
- Completion date
- May 31, 2006
- Enrollment
- 1,997 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.